Tag Archives: PRGS

Top Tech Stocks To Watch For 2021

Pandora (NYSE:P)is hitting the “last dance” phase of its life as a stand-alone public company, and if anyone wants to outbid Sirius XM Radio (NASDAQ:SIRI)for the streaming music pioneer they better speak up soon. Sirius XM announced the all-stock deal initially valued at $3.5 billion on Monday.

Sirius XM didn’t offer much of a premium for Pandora, and with the satellite radio operator’s stock taking a hit on Monday the markup narrowed even more. Sirius XM is exchanging every share of Pandora with 1.44 shares of its own stock, a deal that was worth $10.05 a share for Pandora investors when the deal was announced — but down to $9.01 by Monday’s close. Shares of Pandora entered the week priced at $9.09.

If anyone wants to sweep Pandora off its feet with a sweeter offer, the stage is set. Come in and make a low double-digit offer and it will be hard for the board to stick to the original plan. However, that just doesn’t seem likely. RBC Capital analyst Mark Mahaney doesn’t see this turning into a bidding war. He argues that Spotify (NYSE:SPOT), Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL), and Amazon.com (NASDAQ:AMZN) are unlikely to step up to the plate at this point. He’s right.

Top Tech Stocks To Watch For 2021: SharpSpring, Inc.(SHSP)

SharpSpring, Inc. (the “Company”) is a cloud-based marketing technology company. The Company’s products are designed to improve the way that businesses communicate with their prospects and customers to increase sales. The Company’s flagship SharpSpring marketing automation platform uses advanced features such as web tracking, lead scoring and automated workflow to help businesses deliver the right message to the right customer at the right time. All of our products are designed and built as Software as Service (or SaaS) offerings. We provide our products primarily on a subscription basis, with additional fees charged if specified volume limits are exceeded by our customers.

We operate globally with offices on three continents through SharpSpring, Inc., a Delaware corporation, and our wholly owned subsidiaries that consist of (i) SharpSpring Technologies, Inc., a Delaware corporation; (ii) InterInbox SA, a Swiss corporation; (iii) ERNEPH 2012A (Pty) Ltd.   Advisors’ Opinion:


    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

  • [By Stephan Byrd]

    SharpSpring Inc (NASDAQ:SHSP) major shareholder Cat Rock Capital Management Lp purchased 81,111 shares of the business’s stock in a transaction on Friday, September 21st. The stock was acquired at an average price of $13.32 per share, with a total value of $1,080,398.52. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.


    For the details of Cat Rock Capital Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Cat+Rock+Capital+Management+LP

    These are the top 5 holdings of Cat Rock Capital Management LPTransDigm Group Inc (TDG) – 311,175 shares, 36.47% of the total portfolio. Shares added by 7.62%CarGurus Inc (CARG) – 2,575,310 shares, 30.38% of the total portfolio. Shares added by 138.50%Facebook Inc (FB) – 269,513 shares, 17.78% of the total portfolio. Shares added by 25.29%Star Group LP (SGU) – 3,032,551 shares, 10.09% of the total portfolio. Shares reduced by 0.58%ShotSpotter Inc (SSTI) – 311,862 shares,

Top Tech Stocks To Watch For 2021: Mitek Systems, Inc.(MITK)

Mitek Systems, Inc. develops, markets and sells proprietary mobile capture and identity verification software solutions for enterprise customers.

Our mobile capture and identify verification technologies are embedded into the mobile applications of leading brands across the globe to improve usability while minimizing risk. They serve the needs of any regulated business that has Know Your Customer (“KYC”) obligations.

By licensing our proprietary technology, enterprise customers improve customer acquisition and other key objectives including securing high risk transactions, verification for age sensitive and age-restricted commerce, and meeting KYC and other compliance regulations.

Our technology uses advanced algorithms to correct image distortion, extract relevant data, route images to their desired location and process transactions. As of September 30, 2015, we have been granted 22 patents and have an additional 21 patent applications pending.   Advisors’ Opinion:

  • [By Shane Hupp]

    MITK has been the topic of a number of recent research reports. Benchmark raised Mitek Systems from a “hold” rating to a “buy” rating and set a $12.00 target price on the stock in a research report on Tuesday, November 27th. BidaskClub downgraded Mitek Systems from a “buy” rating to a “hold” rating in a research report on Friday, December 7th. Finally, ValuEngine raised Mitek Systems from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, January 2nd. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $13.67.

    ILLEGAL ACTIVITY NOTICE: “Investors Buy Large Volume of Put Options on Mitek Systems (MITK)” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at www.tickerreport.com/banking-finance/4219568/investors-buy-large-volume-of-put-options-on-mitek-systems-mitk.html.

    About Mitek Systems

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Mitek Systems (MITK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    Mitek Systems Inc. (NASDAQ: MITK) dropped more than 19% Tuesday to set a new 52-week low of $6.85. Shares closed at $8.50 on Monday and the stock’s 52-week high is $10.55. Volume totaled around 3.1 million, about 15 times the daily average. The company announced last night that its long-time CEO is leaving.

Top Tech Stocks To Watch For 2021: Progress Software Corporation(PRGS)

Progress Software Corporation provides software solutions for various industries worldwide. Its OpenEdge segment offers Progress OpenEdge, a development software, which builds multi-language applications for secure deployment across various platforms and mobile devices, as well as cloud; and Progress Corticon, a business rules management system that enables applications with decision automation and change process, and decision-related insight capabilities. The companys Data Connectivity and Integration segment provides Progress DataDirect Connect software, which offers data connectivity using industry-standard interfaces to connect applications running on various platforms; and Progress DataDirect Cloud, a software-as-a-service (SaaS) based connection management service that simplifies SQL access to a spectrum of cloud-based data sources through a single standards-based interface. Its Application Development and Deployment segment offers Telerik Dev Tools, a design, quality assurance, debugging, and reporting suite; Telerik Dev Cloud, a cloud-based application design, deployment, hosting, and testing suite; Telerik Platform, an end-to-end application lifecycle solution; Telerik ALM, an application lifecycle management suite for testing Web, mobile, and desktop applications; Telerik Sitefinity, a Web content management and customer analytics platform; Progress Rollbase, a software that allows the creation of SaaS business applications; and Modulus Node.js and MongoDB cloud platforms that helps in the development of business and consumer applications. The company also provides project management, implementation, custom development, programming, and other services, as well as services to Web-enable applications; and training services. It sells its products directly to end-users, as well as indirectly to application partners, original equipment manufacturers, and system integrators. The company was founded in 1981 and is headquartered in Bedford, Massachusetts.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Progress Software Corp (NASDAQ:PRGS) saw a large growth in short interest in September. As of September 14th, there was short interest totalling 1,252,744 shares, a growth of 39.0% from the August 31st total of 901,413 shares. Based on an average daily volume of 440,053 shares, the short-interest ratio is presently 2.8 days. Currently, 2.8% of the shares of the stock are sold short.

  • [By Stephan Byrd]

    Progress Software Corp (NASDAQ:PRGS) was the recipient of some unusual options trading activity on Thursday. Stock traders bought 775 put options on the stock. This is an increase of approximately 1,170% compared to the typical daily volume of 61 put options.

  • [By Steve Symington]

    Shares of Progress Software Inc. (NASDAQ:PRGS)are plunging, down 16.7% as of 1:45 p.m. EDT, after the strategic business applications specialist announced mixed third-quarter 2018 results and reduced its full-year guidance.

  • [By Garrett Baldwin]

    Get an exclusive invitation to meet Tim before everyone else right here.

    The Top Stock Market Stories for Wednesday
    The U.S. markets are preparing for the eighth interest rate hike since 2015, and the Federal Reserve may not be done yet. Markets are weighing the possibility that the Fed may raise rates one more time this year (in December). The hikes come as the Fed is attempting to shrink its $4.5 trillion balance sheet. When Powell speaks this afternoon, expect a few questions about the impact of the trade war between the United States and China. Reporters will also likely want to know about geopolitical risks to the U.S. economy and how they might affect growth in a higher-interest-rate environment. Yesterday, U.S. President Donald Trump gave a speech before the United Nations General Assembly. During his talk, Trump praised the U.S. economy and defended his administration’s actions this year on trade. Trump said that the United States will no longer endure “abuse” from other trade partners. The U.S. Trade Representative Robert Lighthizer also said Tuesday that the U.S. is prepared to proceed on a new trade deal with Mexico without the participation of Canada. Oil prices are in focus after President Trump called out OPEC members before the U.N. on Tuesday. During his talk, Trump accused OPEC and non-OPEC participants in collusion efforts on production and prices of ripping off the rest of the world.
    Three Stocks to Watch Today: NKE, SVMK, DB
    Shares of Nike Inc. (NYSE: NKE) fell 3.5% after the sports apparel giant reported earnings after the bell. The company topped earnings expectations and reported profit growth of 15%. However, investors took some profits off the table. Shares of Nike stock are up more than 35% on the year. SVMK, the parent company of SurveyMonkey, has priced its upcoming IPO at $12 per share. That figure is above analysts’ initial range expectation of $9 to $11 per share. The firm expects to reach a market capitalization of $1.46 bil

Top Tech Stocks To Watch For 2021: Amgen Inc.(AMGN)

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Every so often on Rule Breaker Investing, Motley Fool co-founder David Gardner shares a five-stock sampler — five active recommendations in either Rule Breakers or Stock Advisor that are poised for great things. This week: five healthcare companies that are innovating treatments and drugs that are making the world healthier. Learn more about Amgen (NASDAQ:AMGN), bluebird bio (NASDAQ:BLUE), Editas Medicine (NASDAQ:EDIT), Illumina (NASDAQ:ILMN), and Vertex Pharmaceuticals (NASDAQ:VRTX) and why you should add these exciting and inspiring stocks to your watch list.

  • [By ]

    Even though ABBV has more than 100 patents covering Humira, and despite its 2017 patent win over Amgen (Nasdaq: AMGN) requiring AMGN to wait until 2023 before issuing its own copy of Humira, the battle for generic Humira isn’t over.